Posts tagged Amgen Inc


Stock Update (NASDAQ:AMGN): Here’s Why Amgen, Inc. Shares Are Falling 10% Today

Amgen, Inc. (NASDAQ:AMGN) shares are falling nearly 10% in Friday’s trading session, leaving investors scratching their heads …

Read more

Cowen Positive on Cytokinetics, Inc. (CYTK) as Amgen, Inc. (AMGN) Opts-in to Advance Omecamtiv to Phase 3

Cowen top analyst Ritu Baral chimes in on Cytokinetics, Inc. (NASDAQ:CYTK) after Amgen, Inc. (NASDAQ:AMGN) …

Read more

Morgan Stanley Weighs In on Valeant Pharmaceuticals Intl Inc (VRX) and Amgen, Inc. (AMGN) Following Headquarter Visit and FDA CRL

Morgan Stanley analysts were out today with commentary on healthcare giants Valeant Pharmaceuticals Intl Inc (NYSE:VRX) …

Read more

RBC Analyst Michael Yee Sees Bright Future For Biotech Stocks

Overhang and political rhetoric have paved a tough road for biotech stocks in the past …

Read more

Biotech Outlook: Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG), Amgen, Inc. (AMGN), Biogen Inc (BIIB), Regeneron Pharmaceuticals Inc (REGN)

Yesterday, Jennifer asked is Valeant Pharmaceuticals the proverbial canary in the coal mine for the …

Read more

Zacks’ Top Biotech Stocks: Gilead Sciences, Inc. (GILD), Celgene Corporation (CELG), Amgen, Inc. (AMGN)

The biotech sector, which has outperformed over the last few years, has not exactly had …

Read more

Piper Jaffray Pounds the Table on Gilead Sciences, Inc. (GILD) and Amgen, Inc. (AMGN)

To kick off biotech in 2016, analyst Joshua Schimmer of Piper Jaffray pounds the table …

Read more

Unilife Corp (UNIS) Surges Following Agreement With Amgen, Inc. (AMGN)

Unilife Corp (NASDAQ: UNIS) is having an incredible day in the market today after disclosing an SEC …

Read more

Tuesday Morning’s Market Insights: Apple Inc. (AAPL), Walt Disney Co (DIS), QUALCOMM, Inc. (QCOM), Amgen, Inc. (AMGN)

Apple Inc. (NASDAQ:AAPL) was trading down 1% to about $111 in pre-market trading this morning following …

Read more

Stock Update (NASDAQ:CYTK): Cytokinetics, Inc. and Amgen Announce Positive Top-Line Results From COSMIC-HF, a Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

Cytokinetics, Inc. (NASDAQ:CYTK) and Amgen, Inc. (NASDAQ:AMGN) announced that data from the expansion phase of …

Read more